| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-08 22:49:09 UTC |
|---|
| Updated at | 2022-09-08 22:49:09 UTC |
|---|
| NP-MRD ID | NP0275166 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 2-[(2r,8r,11r,14s,17r)-17-[(2s)-butan-2-yl]-3,6,9,12,15,18-hexahydroxy-8-(1h-indol-3-ylmethyl)-11,14-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid |
|---|
| Description | Desotamide belongs to the class of organic compounds known as cyclic peptides. Cyclic peptides are compounds containing a cyclic moiety bearing a peptide backbone. 2-[(2r,8r,11r,14s,17r)-17-[(2s)-butan-2-yl]-3,6,9,12,15,18-hexahydroxy-8-(1h-indol-3-ylmethyl)-11,14-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid was first documented in 2014 (PMID: 25072108). Based on a literature review a significant number of articles have been published on desotamide (PMID: 25747118) (PMID: 34073984) (PMID: 32727132) (PMID: 32002605) (PMID: 29431987) (PMID: 29129945). |
|---|
| Structure | CC[C@H](C)[C@H]1N=C(O)[C@H](CC(C)C)N=C(O)[C@@H](CC(C)C)N=C(O)[C@@H](CC2=CNC3=CC=CC=C23)N=C(O)CN=C(O)[C@@H](CC(O)=N)N=C1O InChI=1S/C35H52N8O7/c1-7-20(6)30-35(50)42-27(15-28(36)44)31(46)38-17-29(45)39-26(14-21-16-37-23-11-9-8-10-22(21)23)33(48)40-24(12-18(2)3)32(47)41-25(13-19(4)5)34(49)43-30/h8-11,16,18-20,24-27,30,37H,7,12-15,17H2,1-6H3,(H2,36,44)(H,38,46)(H,39,45)(H,40,48)(H,41,47)(H,42,50)(H,43,49)/t20-,24+,25-,26+,27+,30+/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C35H52N8O7 |
|---|
| Average Mass | 696.8500 Da |
|---|
| Monoisotopic Mass | 696.39590 Da |
|---|
| IUPAC Name | Not Available |
|---|
| Traditional Name | Not Available |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC[C@H](C)[C@H]1N=C(O)[C@H](CC(C)C)N=C(O)[C@@H](CC(C)C)N=C(O)[C@@H](CC2=CNC3=CC=CC=C23)N=C(O)CN=C(O)[C@@H](CC(O)=N)N=C1O |
|---|
| InChI Identifier | InChI=1S/C35H52N8O7/c1-7-20(6)30-35(50)42-27(15-28(36)44)31(46)38-17-29(45)39-26(14-21-16-37-23-11-9-8-10-22(21)23)33(48)40-24(12-18(2)3)32(47)41-25(13-19(4)5)34(49)43-30/h8-11,16,18-20,24-27,30,37H,7,12-15,17H2,1-6H3,(H2,36,44)(H,38,46)(H,39,45)(H,40,48)(H,41,47)(H,42,50)(H,43,49)/t20-,24+,25-,26+,27+,30+/m0/s1 |
|---|
| InChI Key | LJGXNPVJAKBNOK-ZXCSEHFOSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as cyclic peptides. Cyclic peptides are compounds containing a cyclic moiety bearing a peptide backbone. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Cyclic peptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cyclic alpha peptide
- 3-alkylindole
- Indole or derivatives
- Indole
- Benzenoid
- Substituted pyrrole
- Heteroaromatic compound
- Cyclic carboximidic acid
- Pyrrole
- Azacycle
- Organoheterocyclic compound
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Polyol
- Carboximidic acid derivative
- Carboximidic acid
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Song Y, Li Q, Liu X, Chen Y, Zhang Y, Sun A, Zhang W, Zhang J, Ju J: Cyclic Hexapeptides from the Deep South China Sea-Derived Streptomyces scopuliridis SCSIO ZJ46 Active Against Pathogenic Gram-Positive Bacteria. J Nat Prod. 2014 Aug 22;77(8):1937-41. doi: 10.1021/np500399v. [PubMed:25072108 ]
- Li Q, Song Y, Qin X, Zhang X, Sun A, Ju J: Identification of the Biosynthetic Gene Cluster for the Anti-infective Desotamides and Production of a New Analogue in a Heterologous Host. J Nat Prod. 2015 Apr 24;78(4):944-8. doi: 10.1021/acs.jnatprod.5b00009. Epub 2015 Mar 6. [PubMed:25747118 ]
- Xu R, Song Y, Li J, Ju J, Li Q: Chemical Synthesis and Structure-Activity Relationship Study Yield Desotamide a Analogues with Improved Antibacterial Activity. Mar Drugs. 2021 May 24;19(6). pii: md19060303. doi: 10.3390/md19060303. [PubMed:34073984 ]
- Fazal A, Webb ME, Seipke RF: The Desotamide Family of Antibiotics. Antibiotics (Basel). 2020 Jul 27;9(8). pii: antibiotics9080452. doi: 10.3390/antibiotics9080452. [PubMed:32727132 ]
- Ding W, Dong Y, Ju J, Li Q: The roles of genes associated with regulation, transportation, and macrocyclization in desotamide biosynthesis in Streptomyces scopuliridis SCSIO ZJ46. Appl Microbiol Biotechnol. 2020 Mar;104(6):2603-2610. doi: 10.1007/s00253-020-10414-4. Epub 2020 Jan 31. [PubMed:32002605 ]
- Tsutsumi LS, Elmore JM, Dang UT, Wallace MJ, Marreddy R, Lee RB, Tan GT, Hurdle JG, Lee RE, Sun D: Solid-Phase Synthesis and Antibacterial Activity of Cyclohexapeptide Wollamide B Analogs. ACS Comb Sci. 2018 Mar 12;20(3):172-185. doi: 10.1021/acscombsci.7b00189. Epub 2018 Feb 20. [PubMed:29431987 ]
- Tsutsumi LS, Tan GT, Sun D: Solid-phase synthesis of cyclic hexapeptides wollamides A, B and desotamide B. Tetrahedron Lett. 2017 Jul 5;58(27):2675-2680. doi: 10.1016/j.tetlet.2017.05.084. Epub 2017 May 25. [PubMed:29129945 ]
- Chen YX, Liu C, Liu N, Wu Y, Zhao QJ, Hu HG, Li X, Zou Y: Total Synthesis and Antibacterial Study of Cyclohexapeptides Desotamide B, Wollamide B and Their Analogs. Chem Biodivers. 2018 Jan;15(1). doi: 10.1002/cbdv.201700414. Epub 2017 Dec 27. [PubMed:29125222 ]
- Kamjam M, Sivalingam P, Deng Z, Hong K: Deep Sea Actinomycetes and Their Secondary Metabolites. Front Microbiol. 2017 May 1;8:760. doi: 10.3389/fmicb.2017.00760. eCollection 2017. [PubMed:28507537 ]
- Li Q, Qin X, Liu J, Gui C, Wang B, Li J, Ju J: Deciphering the Biosynthetic Origin of L-allo-Isoleucine. J Am Chem Soc. 2016 Jan 13;138(1):408-15. doi: 10.1021/jacs.5b11380. Epub 2015 Dec 28. [PubMed:26669414 ]
- LOTUS database [Link]
|
|---|